S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Uniphar (UPR) Share Forecast, Price & News

GBX 285
+2.50 (+0.88%)
(As of 05/27/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
12,196 shs
Average Volume
34,222 shs
Market Capitalization
£778.09 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive UPR News and Ratings via Email

Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter.

Uniphar logo

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.


Uniphar PLC - Holding(s) in Company
Uniphar PLC : Half Year Trading Update and Notice of Results
Uniphar PLC : Acquisition of CoRRect Medical GmbH
Blackfinch Spr. Regulatory News
See More Headlines

Industry, Sector and Symbol

Medical Care Facilities
Year Founded

Sales & Book Value

Annual Sales
£1.94 billion
Cash Flow
GBX 29.82 per share
Book Value
GBX 92.10 per share


Pretax Margin




Free Float
Market Cap
£778.09 million
Not Optionable

Company Calendar

Ex-Dividend for 5/13 Dividend
Dividend Payable


Overall MarketRank

1.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.8Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -

Uniphar (LON:UPR) Frequently Asked Questions

Is Uniphar a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Uniphar in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Uniphar stock.
View analyst ratings for Uniphar
or view top-rated stocks.

How often does Uniphar pay dividends? What is the dividend yield for Uniphar?

Uniphar announced a dividend on Tuesday, March 1st. Investors of record on Thursday, April 21st will be given a dividend of GBX 0.01 per share on Friday, May 13th. This represents a dividend yield of 0.34%. The ex-dividend date is Thursday, April 21st. This is a positive change from Uniphar's previous dividend of GBX 0.01. The official announcement can be accessed at this link.
View Uniphar's dividend history

Is Uniphar a good dividend stock?

Uniphar pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.95%. The dividend payout ratio of Uniphar is 0.14%. This payout ratio is at a healthy, sustainable level, below 75%.
View Uniphar's dividend history.

Who are Uniphar's key executives?
Uniphar's management team includes the following people:
  • Mr. Gerard Rabbette B.Comm FCA, CEO & Exec. Director
  • Mr. Timothy Dolphin B.Comm FCA, CFO & Exec. Director
  • Mr. Padraic Dempsey, Chief Commercial Officer
  • Mr. Seamus Egan, Head of Corp. Devel. & Investor Relations
  • Ms. Aisling McCarthy, Gen. Counsel & Company Sec.
  • Mr. Dermot Ryan, Managing Director
What is Uniphar's stock symbol?

Uniphar trades on the London Stock Exchange (LON) under the ticker symbol "UPR."

How do I buy shares of Uniphar?

Shares of UPR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Uniphar's stock price today?

One share of UPR stock can currently be purchased for approximately GBX 285.

How much money does Uniphar make?

Uniphar has a market capitalization of £778.09 million and generates £1.94 billion in revenue each year.

How many employees does Uniphar have?

Uniphar employs 2,850 workers across the globe.

What is Uniphar's official website?

The official website for Uniphar is www.uniphar.ie.

How can I contact Uniphar?

The company can be reached via phone at 353 1 428 7777.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.